Mario Gabelli's TEVA Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 89.2K shares of Teva Pharmaceutical Industries Limited (TEVA) worth $1.8 M, representing 0.02% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Mario Gabelli has maintained a strategic position in TEVA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2021, adding 29.2K shares. Largest reduction occurred in Q4 2024, reducing 24.1K shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Teva Pharmaceutical Industries Limited (TEVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teva Pharmaceutical Industries Limited (TEVA) Trades by Mario Gabelli
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2021 | +168,400 | New Buy | 168,400 | $11.54 |
| Q2 2021 | +29,200 | Add 17.34% | 197,600 | $9.90 |
| Q4 2021 | -10,000 | Reduce 5.06% | 187,600 | $8.01 |
| Q1 2022 | +500 | Add 0.27% | 188,100 | $9.39 |
| Q2 2022 | -12,200 | Reduce 6.49% | 175,900 | $7.52 |
| Q3 2022 | -17,500 | Reduce 9.95% | 158,400 | $8.07 |
| Q4 2022 | -1,600 | Reduce 1.01% | 156,800 | $9.12 |
| Q1 2023 | -4,400 | Reduce 2.81% | 152,400 | $8.85 |
| Q2 2023 | -4,000 | Reduce 2.62% | 148,400 | $7.53 |
| Q3 2023 | -600 | Reduce 0.40% | 147,800 | $10.20 |
| Q1 2024 | -2,750 | Reduce 1.86% | 145,050 | $14.11 |
| Q2 2024 | -10,800 | Reduce 7.45% | 134,250 | $16.25 |
| Q3 2024 | -4,550 | Reduce 3.39% | 129,700 | $18.02 |
| Q4 2024 | -24,100 | Reduce 18.58% | 105,600 | $22.04 |
| Q1 2025 | -12,400 | Reduce 11.74% | 93,200 | $15.37 |
| Q2 2025 | -4,000 | Reduce 4.29% | 89,200 | $16.76 |
Mario Gabelli's Teva Pharmaceutical Industries Limited Investment FAQs
Mario Gabelli first purchased Teva Pharmaceutical Industries Limited (TEVA) in Q1 2021, acquiring 168,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Teva Pharmaceutical Industries Limited (TEVA) for 19 quarters since Q1 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli's largest addition to Teva Pharmaceutical Industries Limited (TEVA) was in Q1 2021, adding 168,400 shares worth $1.94 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 89,200 shares of Teva Pharmaceutical Industries Limited (TEVA), valued at approximately $1.8 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Teva Pharmaceutical Industries Limited (TEVA) represents approximately 0.02% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli's peak holding in Teva Pharmaceutical Industries Limited (TEVA) was 197,600 shares, as reported at the end of Q2 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.